公开(公告)号：US20240307498A1

公开(公告)日：2024-09-19

申请号：US18681207

申请日：2022-08-05

Applicant: ReBalance Health, Inc.

Inventor： Russell GLENN ,  Justin HAI

IPC: A61K38/25 ,  A61K9/20 ,  A61K31/704 ,  A61K31/706 ,  A61K31/714 ,  A61K47/18 ,  A61K47/26

CPC classification number: A61K38/25 ,  A61K9/2013 ,  A61K31/704 ,  A61K31/706 ,  A61K31/714 ,  A61K47/183 ,  A61K47/26

Abstract: Described herein are sermorelin peptide compositions formulated for high oral bioavailability and high rates of absorption for treatment in a variety of applications, such as treatment of low testosterone, diminished endurance and energy, deficient immune system, slow metabolism, deficient cognitive function, poor sleep health, and poor bone health.